Font Size: a A A

Clinical Observation On Modified Qianjin Weijing Decoction Of Bronchiectasis Secondary Infection (Phlegm-Heat Obstructing Lung) And The Effect On IL-8

Posted on:2017-02-26Degree:MasterType:Thesis
Country:ChinaCandidate:L X MaFull Text:PDF
GTID:2284330482986328Subject:Integrative Medicine
Abstract/Summary:PDF Full Text Request
Objective:Clincal observation on modified Qianjin Weijing decoction of bronchiectasis secondary infection(phlegm-heat obstructing lung) and the effect on IL-8.Methods:A randomized controlled trial study method to 70 cases of patients with bronchiectasis secondary infection(phlegm-heat obstructing lung) were divided into treatment group (35 cases) and control group (35 cases), the control group was given oral Avelox and Eucalyptol treatment, the treatment group to the control group on the basis of modified Qianjin Weijing decoction. Treatment for 10 days. Observe two groups of patients in the clinical symptoms and signs before and after medication and the change of serum IL-8.Results:1. modified Qianjin Weijing decoction treating bronchiectasis secondary infection(phlegm-heat obstructing lung) of clinical curative effect is distinct.The total effective rate:treatment group is 93.94%,control group is 88.57%, compared the two groups have statistical significance,with no bad raction.2. modified Qianjin Weijing decoction can significantly improve TCM syndrome,especially in cough、yellow sputum、dry、astriction,the treatment group is better than that in control group (P< 0.05).3.the two groups can reduce the content of serum IL-8, before and after treatment comparison was statistically significant (P<0.05).Comparison between groups, the treatment group is obviously better than the extent of the content of serum IL-8 in the control group, with statistical significance (P< 0.05).4.Two groups were all decreased white blood cell count, the content changes before and after treatment was statistically significant (P<0.05); Comparison between the two groups after treatment groups was statistically significant (P<0.05), and the treatment group is better than the control group.Conclusion:1. modified Qianjin Weijing decoction treating bronchiectasis secondary infection(phlegm-heat obstructing lung) of clinical curative effect is distinct, can improve the patients’clinical syndromes. especially in cough、yellow sputum、dry、astriction.2. modified Qianjin Weijing decoction can effectively reduce the bronchiectasis secondary infection(phlegm-heat obstructing lung)patients with serum IL-8 levels.
Keywords/Search Tags:Modified Qianjin Weijing decoction, Bronchiectasis secondary infection, phlegm-heat obstructing lung, IL-8
PDF Full Text Request
Related items
Clinical Effect Of Jiawei Qianjin Weijing Decoction On The Acute Exacerbation Of Bronchiectasis With Phlegm-heat Obstructing Lung Syndrome
Clinical Observation Of Jiawei Weijing Decoction Combined With Amikacin Atomization In The Treatment Of Phlegm-Heat Obstructing Lung Type In Acute Exacerbation Of Bronchiectasis
Clinical Observation On Modified Erchenpingwei Decoction In The Treatment Of Bronchiectasis Secondary Pulmonary Infection (Lung Phlegm-Turbidity With Heat) And Its Effect On Serum CRP
Observation On The Clinical Efficacy Of Modified Xiebaisan In The Treatment Of Bronchiectasis Complicated With Infection (phlegm-heat Obstructing The Lung Type
Observation Of The Curative Effect Of Lou Qin Zhisou Decoction In The Treatment Of Bronchiectasis Complicated By Infection With Phlegm-heat Obstructing The Lung Syndrome
Clinical Observation On The Treatment Of Bronchiectasis And Infection With Phlegm-heat Obstructing The Lungs With Luoqin Qingfei Huatan Decoctio
Clinical Observation Of Qingjin Huatan Decoction In The Treatment Of Bronchiectasis Complicated By Infection (phlegm-heat Obstructing The Lung Syndrome)
Observation On The Curative Effect Of Jiawei Weijing Decoction In Treating Bronchiectasis With Infection Of Phlegm-heat Stagnation And Lung Syndrome
Study On The Mechanism Of Qianjin Weijing Decoction In The Treatment Of Bronchiectasis Based On Network Pharmacology
10 Clinical Study On Zhike No.1 Prescription In The Treatment Of Bronchiectasis With Phlegm-heat Obstructing The Lung Syndrome